HeartBeam has submitted a 510 (k) application to the US Food and Drug Administration (FDA) for its 12-lead electrocardiogram ...

The atrial fibrillation (AF) device market is experiencing rapid growth, fueled by the rising prevalence of atrial fibrillation, increasing awareness of early diagnosis, and advancements in medical ...

The FDA submission is backed by robust data from the VALID-ECG pivotal study, which enrolled 198 patients across five ...

Smart ring maker Circular announced its next-gen Ring 2 with ECG (electrocardiogram) functionality and AFib (atrial fibrillation) detection at CES 2025 Unveiled on Sunday in Las Vegas. The ...

As per a survey, only a fraction of smartwatch users share details of their health stats with a doctor, a misstep that could ...

The company announced that the ECG app is now available in the EU and Australia. As you might expect, the ECG app lets you ...

Atrial fibrillation (AF) and heart failure (HF ... The simultaneous integration of long-term non-invasive ECG and ICG signal recordings and real-time arrhythmia detection, would be a significant ...

Garmin (GRMN) announced the ECG App is now available to customers in Australia and the European Union with a compatible Garmin smartwatch, ...

HeartBeam (NASDAQ: BEAT) , a medical technology company advancing cardiac care, has submitted a 510 (k) application to the U.S. Food and Drug Administration (“FDA”) for its 12-lead electrocardiogram ( ...

The ECG App allows users to record their heart rhythm and check for signs of atrial fibrillation (AFib) whenever they want. Customers can use the ECG App to record a 30-second ECG and view their ...